Univercells Technologies, a Donaldson Life Sciences business

What we do: Univercells Technologies is a global leader in innovative biomanufacturing technologies, specializing in cost-effective viral production solutions from research and development to commercial scales. The company offers a comprehensive portfolio that leverages process intensification and chaining to meet the growing demand for viral vectors and vaccines, primarily serving the cell and gene therapy, viral vaccine, and advanced therapeutics industries.

Where we are located: The company is headquartered in Nivelles, Walloon Region, Belgium, at Chemin de la Vieille Cour 56a, 1400.

Short history: Founded in 2020 in Belgium, Univercells Technologies builds upon years of expertise and technology developed by the Univercells group. It is now part of Donaldson Company, a global filtration and life sciences solutions provider, following its acquisition to expand Donaldson’s life sciences portfolio.

Organization & culture: Univercells Technologies operates with a focus on innovation and customer success, supporting manufacturing excellence with a high customer satisfaction rate of 92%. The company emphasizes scalable, efficient, and automated bioprocessing solutions, fostering a culture of technological advancement and collaboration within the life sciences sector.